Stocks
Hologic Financial Statements (HOLX) |
||||||||||
| Hologicsmart-lab.ru | % | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | 2024Q4 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 02.05.2024 | 03.05.2024 | 29.07.2024 | 30.07.2024 | 04.11.2024 | 04.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 1 018 | 1 018 | 1 011 | 1 011 | 987.9 | 4 029 | |||
| Operating Income, bln rub | 210.4 | 243.3 | 263.9 | 263.9 | 230.1 | 1 001 | ||||
| EBITDA, bln rub | ? | 210.4 | 317.5 | 336.2 | 344.9 | 328.1 | 1 327 | |||
| Net profit, bln rub | ? | 169.9 | 169.9 | 194.5 | 194.5 | 178.6 | 737.5 | |||
| OCF, bln rub | ? | 0.000 | 292.4 | 405.8 | 405.8 | 1 104 | ||||
| CAPEX, bln rub | ? | 0.000 | 28.0 | 43.9 | 43.9 | 115.8 | ||||
| FCF, bln rub | ? | 0.000 | 264.4 | 361.9 | 361.9 | 988.2 | ||||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 331.9 | 319.2 | 304.4 | 304.4 | 327.6 | 1 256 | ||||
| Cost of production, bln rub | 475.5 | 455.3 | 443.1 | 443.1 | 430.2 | 1 772 | ||||
| R&D, bln rub | 74.6 | 74.6 | 64.1 | 64.1 | 67.3 | 270.1 | ||||
| Interest expenses, bln rub | 32.3 | 32.3 | 31.9 | 31.9 | 32.0 | 128.1 | ||||
| Assets, bln rub | 8 714 | 8 714 | 8 890 | 8 890 | 9 156 | 9 156 | ||||
| Net Assets, bln rub | ? | 4 844 | 4 844 | 4 951 | 4 951 | 5 130 | 5 130 | |||
| Debt, bln rub | 2 552 | 2 569 | 2 543 | 2 559 | 2 535 | 2 535 | ||||
| Cash, bln rub | 2 180 | 2 180 | 2 439 | 2 439 | 2 334 | 2 334 | ||||
| Net debt, bln rub | 371.5 | 388.5 | 104.0 | 120.1 | 201.0 | 201.0 | ||||
| Ordinary share price, rub | 78.0 | 78.0 | 74.3 | 80.8 | 66.6 | |||||
| Number of ordinary shares, mln | 235.9 | 235.9 | 234.6 | 234.6 | 233.8 | 233.8 | ||||
| Market cap, bln rub | 18 390 | 18 390 | 0 | 17 419 | 18 893 | 15 560 | ||||
| EV, bln rub | ? | 18 761 | 18 778 | 104 | 17 539 | 19 094 | 15 761 | |||
| Book value, bln rub | 4 844 | 800 | 4 951 | 972 | 5 130 | 5 130 | ||||
| EPS, rub | ? | 0.72 | 0.72 | 0.83 | 0.83 | 0.76 | 3.15 | |||
| FCF/share, rub | 0.00 | 1.12 | 1.54 | 1.54 | 0.00 | 4.23 | ||||
| BV/share, rub | 20.5 | 3.39 | 21.1 | 4.14 | 21.9 | 21.9 | ||||
| EBITDA margin, % | ? | 20.7% | 31.2% | 33.2% | 34.1% | 33.2% | 32.9% | |||
| Net margin, % | ? | 16.7% | 16.7% | 19.2% | 19.2% | 18.1% | 18.3% | |||
| FCF yield, % | ? | 3.72% | 5.16% | 5.82% | 4.28% | 6.35% | ||||
| ROE, % | ? | 9.63% | 9.63% | 14.2% | 14.2% | 15.4% | 14.4% | |||
| ROA, % | ? | 5.35% | 5.35% | 7.89% | 7.89% | 8.62% | 8.05% | |||
| P/E | ? | 39.4 | 39.4 | 0.00 | 24.8 | 23.9 | 21.1 | |||
| P/FCF | 26.9 | 19.4 | 0.00 | 17.2 | 23.4 | 15.7 | ||||
| P/S | ? | 4.64 | 4.64 | 0.00 | 4.37 | 4.69 | 3.86 | |||
| P/BV | ? | 3.80 | 23.0 | 0.00 | 17.9 | 3.68 | 3.03 | |||
| EV/EBITDA | ? | 21.3 | 18.1 | 0.09 | 14.4 | 14.7 | 11.9 | |||
| Debt/EBITDA | 0.42 | 0.37 | 0.09 | 0.10 | 0.16 | 0.15 | ||||
| R&D/CAPEX, % | 266.4% | 146.0% | 146.0% | 233.2% | ||||||
| CAPEX/Revenue, % | 0.00% | 2.75% | 4.34% | 4.34% | 0.00% | 2.87% | ||||
| Hologic shareholders | ||||||||||
